Company: CGCT
Filing Date: 2025-01-29
Form Type: S-1
Source: 0001104659-25-006780
Chunk: 11

Company: Cartesian Growth Corp III
Filing Date: 2025-01-29
Form: S-1
Chunk 11
---
 the related notes included elsewhere in this prospectus, before investing. Unless otherwise stated in this prospectus or the context otherwise requires, references to:

| · | “we,” “us,” “company” or “our company” are to Cartesian    
 Growth Corporation III, a Cayman Islands exempted company; |

| · | “Cantor” are to Cantor Fitzgerald & Co., the representative of the underwriters; |

| · | “Class A ordinary shares” are to our Class A ordinary shares of par value $0.0001 
 per share in the share capital of the company;                                    |

| · | “Class B ordinary shares” are to our Class B ordinary shares of par value $0.0001 
 per share in the share capital of the company;                                    |

| · | “Companies Act” or “Companies Law” are to the Companies Act (Revised) of the 
 Cayman Islands, as the same may be amended from time to time;                |

| · | “completion window” are to (i) the period ending on the date that is 24 months                                                               
 from the closing of this offering, or such earlier date as our board of directors may approve, in which we must complete an initial business 
 combination or (ii) such other time period in which we must complete an initial business combination pursuant to an amendment to             
 our amended and restated memorandum and articles of association, as approved by a special resolution of our shareholders. If we ask our      
 shareholders to approve an amendment to our amended and restated memorandum and articles of association to modify the amount of time we      
 will have to complete an initial business combination, our public shareholders will be offered an opportunity to redeem their public shares; |

| · | “DirectorCo” are to CGC III Sponsor DirectorCo LLC, a Cayman Islands limited liability                                           
 company recently formed to hold founder shares for the benefit of our independent directors, as further discussed under “Initial 
 Shareholders Information,” below;                                                                                                |

| · | “directors” are to our current directors and our director nominees named in this prospectus; |

| · | “equity-linked securities” are to any debt or equity securities that are convertible, exercisable                                  
 or exchangeable for Class A ordinary shares issued in a financing transaction in connection with our initial business combination, 
 including but not limited to a private placement of equity or debt;                                                                |

| · | “Exchange Act” are to the Securities Exchange Act of 1934, as amended;